Acute ischemic stroke is a common cause of morbidity and mortality worldwide.
Thrombolysis with recombinant tissue plasminogen activator and endovascular …

Purpose—Our goal is to provide an overview of the current evidence about components of
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …

Background and Purpose—The authors present an overview of the current evidence and
management recommendations for evaluation and treatment of adults with acute ischemic …

This article represents the update of the European Stroke Initiative Recommendations for
Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic …

Stroke is one of the major causes of disability and mortality worldwide. It is well known that
ischemic stroke can cause gray matter injury. However, stroke also elicits profound white …

This article represents the update of the European Stroke Initiative Recommendations for
Stroke Management. These guidelines cover both ischaemic stroke and transient ischaemic …

Neuroprotection for ischemic stroke refers to strategies, applied singly or in combination, that
antagonize the injurious biochemical and molecular events that eventuate in irreversible …

Background Citicoline is approved in some countries for the treatment of acute ischaemic
stroke. The drug has shown some evidence of efficacy in a pooled analysis. We sought to …

Summary Background Neuroprotection with NA-1 (Tat-NR2B9c), an inhibitor of postsynaptic
density-95 protein, has been shown in a primate model of stroke. We assessed whether NA …

В книге обобщены последние достижения по проблеме ишемического инсульта-одной
из основных причин смертности и ранней инвалидизации больных. Авторы описывают …